GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q2 EPS of $0.08, in-line with the analyst estimate of $0.08. Revenue for the quarter came in at $200.41 million versus the consensus estimate of $193.19 million.

GUIDANCE:

GoodRx Holdings, Inc. sees FY2026 revenue of $790-805 million, versus the consensus of $775.9 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.